Literature DB >> 15800767

Correlation between "malfunctioning events" and catheter-related infections in pediatric cancer patients bearing tunneled indwelling central venous catheter: results of a prospective observational study.

Elio Castagnola1, Giuseppe Fratino, Mariangela Valera, Mareva Giacchino, Riccardo Haupt, Angelo Claudio Molinari.   

Abstract

AIM OF THE STUDY: To evaluate the possible link between malfunctioning events and catheter related infections in indwelling central venous devices in children with cancer. PATIENTS AND METHODS: Prospective observation of 418 devices inserted in 2 Italian tertiary care pediatric cancer centers. The presence of a relationship was identified if a malfunctioning event was followed by a catheter related infection within 10 days, or vice versa.
RESULTS: The 418 catheters were followed for a period of 107,012 days. Among the malfunctioning events 2 out of 141 (1%) were followed by a catheter related infection while among infectious episodes 3 out of 93 (3%) were followed by a malfunctioning event.
CONCLUSIONS: Malfunctioning events followed by catheter related infections and catheter related infections followed by malfunctioning are both rare events in children with cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15800767     DOI: 10.1007/s00520-005-0802-y

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  12 in total

1.  Prevention of intravascular catheter-related infections.

Authors:  L A Mermel
Journal:  Ann Intern Med       Date:  2000-03-07       Impact factor: 25.391

2.  The promise of novel technology for the prevention of intravascular device-related bloodstream infection. II. Long-term devices.

Authors:  Christopher J Crnich; Dennis G Maki
Journal:  Clin Infect Dis       Date:  2002-04-17       Impact factor: 9.079

Review 3.  Biofilm formation: a clinically relevant microbiological process.

Authors:  R M Donlan
Journal:  Clin Infect Dis       Date:  2001-09-20       Impact factor: 9.079

Review 4.  Device-associated infections: a macroproblem that starts with microadherence.

Authors:  R O Darouiche
Journal:  Clin Infect Dis       Date:  2001-09-26       Impact factor: 9.079

5.  Bloodstream infections in children with cancer: a multicentre surveillance study of the Italian Association of Paediatric Haematology and Oncology. Supportive Therapy Group-Infectious Diseases Section.

Authors:  C Viscoli; E Castagnola; M Giacchino; S Cesáro; E Properzi; F Tucci; R M Mura; P Alvisi; G Zanazzo; G Surico; F Bonetti; L De Sio; G Izzi; A Di Cataldo; O Ziino; F Massolo; M Nardi; N Santoro; S Binda
Journal:  Eur J Cancer       Date:  1999-05       Impact factor: 9.162

6.  Thromboembolic complications related to indwelling central venous catheters in children with oncological/haematological diseases: a retrospective study of 362 catheters.

Authors:  A C Molinari; E Castagnola; C Mazzola; M Piacentino; G Fratino
Journal:  Support Care Cancer       Date:  2001-10       Impact factor: 3.603

7.  Mechanical complications related to indwelling central venous catheter in pediatric hematology/oncology patients.

Authors:  G Fratino; C Mazzola; P Buffa; M Torre; E Castagnola; P Magillo; A C Molinari
Journal:  Pediatr Hematol Oncol       Date:  2001 Jul-Aug       Impact factor: 1.969

8.  Central venous catheter-related complications in children with oncological/hematological diseases: an observational study of 418 devices.

Authors:  G Fratino; A C Molinari; S Parodi; S Longo; P Saracco; E Castagnola; R Haupt
Journal:  Ann Oncol       Date:  2005-01-27       Impact factor: 32.976

Review 9.  Thrombotic complications of central venous catheters in children.

Authors:  Janna M Journeycake; George R Buchanan
Journal:  Curr Opin Hematol       Date:  2003-09       Impact factor: 3.284

10.  The relationship between the thrombotic and infectious complications of central venous catheters.

Authors:  I I Raad; M Luna; S A Khalil; J W Costerton; C Lam; G P Bodey
Journal:  JAMA       Date:  1994-04-06       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.